Risk of second non-hematological malignancies among 376,825 breast cancer survivors

Breast Cancer Research and Treatment

Volumn 106, Issue 3, 2007, Pages 439-451

  Brown, Linda Morris ^a   Chen, Bingshu E ^a   Pfeiffer, Ruth M ^a   Schairer, Catherine ^a   Hall, Per ^b   Storm, Hans ^c   Pukkala, Eero ^d   Langmark, Frøydis ^e   Kaijser, Magnus ^b   Andersson, Michael ^c   Joensuu, Heikki ^f   Fosså, Sophie D ^g   Travis, Lois B ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

^c DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^d FINNISH CANCER REGISTRY   (Finland)

^e CANCER REGISTRY OF NORWAY   (Norway)

^f HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^g OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Absolute risks; Breast cancer; Cohort study; Competing risks; Risk; Second cancer; Second malignancies; Survivor; Treatment

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER RISK; CANCER SURVIVOR; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEMATOLOGIC MALIGNANCY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

ADULT; AGED; BREAST NEOPLASMS; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; RISK; SURVIVORS;

EID: 35648952702     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-007-9509-8     Document Type: Article

References (74)

1. Colditz GA, Baer HJ, Tamimi RM (2006) Breast cancer. In: Schottenfeld D, Fraumeni JF Jr (eds) Cancer epidemiology and prevention. Oxford University Press, New York, pp 995-1012
2. American Cancer Society (2006) Cancer Facts and Figures 2006. American Cancer Society, Atlanta
3. Ron E (2003) Cancer risks from medical radiation. Health Phys 85:47-59
4. Rowland J, Mariotto A, Aziz N, Tesauro G, Feuer EJ, Blackman D, Thompson P, Pollack L (2004) Cancer survivorship-United States, 1971-2001. MMWR Morbidity and Mortality Weekly Report 53:526-529
5. Van Leeuwen FE, Travis LB (2005) Second cancers. In: De Vita VT, Hellman S, Rosenberg SA (eds) Cancer: Principles and practice of oncology. Lippincott Williams & Wilkins, Philadelphia, pp 2575-2602
6. Mellemkjaer L, Friis S, Olsen JH, Scelo G, Hemminki K, Tracey E, Andersen A, Brewster DH, Pukkala E, McBride ML, Kliewer EV, Tonita JM, Kee-Seng C, Pompe-Kirn V, Martos C, Jonasson JG, Boffetta P, Brennan P (2006) Risk of second cancer among women with breast cancer. Int J Cancer 118:2285-2292
7. Matesich SM, Shapiro CL (2003) Second cancers after breast cancer treatment. Semin Oncol 30:740-748
8. Bernstein L, Deapen D, Cerhan JR, Schwartz SM, Liff J, McGann-Maloney E, Perlman JA, Ford L (1999) Tamoxifen therapy for breast cancer and endometrial cancer risk. J Natl Cancer Inst 91:1654-1662
9. Curtis RE, Boice JD Jr., Shriner DA, Hankey BF, Fraumeni JF Jr. (1996) Second cancers after adjuvant tamoxifen therapy for breast cancer. J Natl Cancer Inst 88:832-834
10. Swerdlow AJ, Jones ME (2005) Tamoxifen treatment for breast cancer and risk of endometrial cancer: a case-control study. J Natl Cancer Inst 97:375-384
11. Boice JD Jr (2006) Ionizing radiation. In: Schottenfeld D, Fraumeni JF Jr (eds) Cancer epidemiology and prevention. Oxford University Press, New York, pp 259-293
12. Soerjomataram I, Louwman WJ, de Vries E, Lemmens VE, Klokman WJ, Coebergh JW (2005) Primary malignancy after primary female breast cancer in the South of the Netherlands, 1972-2001. Breast Cancer Res Treat 93:91-95
13. Rubino C, Shamsaldin A, Le MG, Labbe M, Guinebretiere JM, Chavaudra J, de Vathaire F (2005) Radiation dose and risk of soft tissue and bone sarcoma after breast cancer treatment. Breast Cancer Res Treat 89:277-288
14. Roychoudhuri R, Evans H, Robinson D, Moller H (2004) Radiation-induced malignancies following radiotherapy for breast cancer. Br J Cancer 91:868-872
15. Deutsch M, Land SR, Begovic M, Wieand HS, Wolmark N, Fisher B (2003) The incidence of lung carcinoma after surgery for breast carcinoma with and without postoperative radiotherapy. Results of National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trials B-04 and B-06. Cancer 98:1362-1368
16. Matheson JB, Burmeister BH, Smithers BM, Gotley D, Harvey JA, Doyle L (2002) Second primary oesophageal cancer following radiation for breast cancer. Radiother Oncol 65:159-163
17. Rubino C, de Vathaire F, Diallo I, Shamsaldin A, Grimaud E, Labbe M, Contesso G, Le M (2002) Radiation dose, chemotherapy and risk of lung cancer after breast cancer treatment. Breast Cancer Res Treat 75:15-24
18. Huang J, Mackillop WJ (2001) Increased risk of soft tissue sarcoma after radiotherapy in women with breast carcinoma. Cancer 92:172-180
19. Ahsan H, Neugut AI (1998) Radiation therapy for breast cancer and increased risk for esophageal carcinoma. Ann Int Med 128:114-117
20. Karlsson P, Holmberg E, Johansson KA, Kindblom LG, Carstensen J, Wallgren A (1996) Soft tissue sarcoma after treatment for breast cancer. Radiother Oncol 38:25-31
21. Doherty MA, Rodger A, Langlands AO, Kerr GR (1993) Multiple primary tumours in patients treated with radiotherapy for breast cancer. Radiother Oncol 26:125-131
22. Neugut AI, Robinson E, Lee WC, Murray T, Karwoski K, Kutcher GJ (1993) Lung cancer after radiation therapy for breast cancer. Cancer 71:3054-3057
23. Shannon VR, Nesbitt JC, Libshitz HI (1995) Malignant pleural mesothelioma after radiation therapy for breast cancer. A report of two additional patients. Cancer 76:437-441
24. Ewertz M, Mouridsen HT (1985) Second cancer following cancer of the female breast in Denmark, 1943-80. Natl Cancer Inst Monogr 68:325-329
25. Travis LB, Aziz N (2007) Therapy-induced neoplasms. In: Camus P, Rosenow E (eds) Drug-induced and iatrogenic lung disease. Hodder Arnold, London
26. Cox J (1994) Moss' radiation oncology rationale, technique, results. Mosby, St. Louis
27. Breslow NE, Day NE (1987) Statistical methods in cancer research. International Agency for Research on Cancer, Lyon, France
28. Sahai H, Khurshid A (1996) Statistics in epidemiology: Methods, techniques, and applications. CRC Press, Boca Raton
29. Preston DL, Lubin JL, Pierce DA (1991) EPICURE user's guide. HiroSoft International Corporation, Seattle
30. Chen BE, Cook RJ (2004) Tests for multivariate recurrent events in the presence of a terminal event. Biostatistics 5:129-143
31. Miller DP, Liu G, De VI, Lynch TJ, Wain JC, Su L, Christiani DC (2002) Combinations of the variant genotypes of GSTP1, GSTM1, and p53 are associated with an increased lung cancer risk. Cancer Res 62:2819-2823
32. Rebbeck TR (1999) Inherited genetic predisposition in breast cancer. A population-based perspective. Cancer 86:2493-2501
33. Maggard MA, O'Connell JB, Lane KE, Liu JH, Etzioni DA, Ko CY (2003) Do young breast cancer patients have worse outcomes? J Surg Res 113:109-113
34. Colleoni M, Rotmensz N, Robertson C, Orlando L, Viale G, Renne G, Luini A, Veronesi P, Intra M, Orecchia R, Catalano G, Galimberti V, Nole F, Martinelli G, Goldhirsch A (2002) Very young women (<35 years) with operable breast cancer: features of disease at presentation. Ann Oncol 13:273-279
35. Chung M, Chang HR, Bland KI, Wanebo HJ (1996) Younger women with breast carcinoma have a poorer prognosis than older women. Cancer 77:97-103
36. Walker RA, Lees E, Webb MB, Dearing SJ (1996) Breast carcinomas occurring in young women (<35 years) are different. Br J Cancer 74:1796-1800
37. Prochazka M, Hall P, Gagliardi G, Granath F, Nilsson BN, Shields PG, Tennis M, Czene K (2005) Ionizing radiation and tobacco use increases the risk of a subsequent lung carcinoma in women with breast cancer: case-only design. J Clin Oncol 23:7467-7474
38. Ford MB, Sigurdson AJ, Petrulis ES, Ng CS, Kemp B, Cooksley C, McNeese M, Selwyn BJ, Spitz MR, Bondy ML (2003) Effects of smoking and radiotherapy on lung carcinoma in breast carcinoma survivors. Cancer 98:1457-1464
39. Gilbert ES, Stovall M, Gospodarowicz M, Van Leeuwen FE, Andersson M, Glimelius B, Joensuu T, Lynch CF, Curtis RE, Holowaty E, Storm H, Pukkala E, van't Veer MB, Fraumeni JF, Boice JD Jr., Clarke EA, Travis LB (2003) Lung cancer after treatment for Hodgkin's disease: focus on radiation effects. Radiat Res 159:161-173
40. Travis LB, Gospodarowicz M, Curtis RE, Clarke EA, Andersson M, Glimelius B, Joensuu T, Lynch CF, Van Leeuwen FE, Holowaty E, Storm H, Glimelius I, Pukkala E, Stovall M, Fraumeni JF Jr, Boice JD Jr, Gilbert E (2002) Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease. J Natl Cancer Inst 94:182-192
41. Anonymous (2000) United National Scientific Committee on the Effects of Atomic Radiation (UNSCEAR). Report to the General Assembly, with scientific annexes. Sources and effects of ionizing radiation. United Nations, New York
42. Van Leeuwen FE, Klokman WJ, Stovall M, Hagenbeek A, van den Belt-Dusebout AW, Noyon R, Boice JD Jr., Burgers JM, Somers R (1995) Roles of radiotherapy and smoking in lung cancer following Hodgkin's disease. J Natl Cancer Inst 87:1530-1537
43. Neugut AI, Murray T, Santos J, Amols H, Hayes MK, Flannery JT, Robinson E (1994) Increased risk of lung cancer after breast cancer radiation therapy in cigarette smokers. Cancer 73:1615-1620
44. Prochazka M, Hall P, Granath F, Czene K (2006) Family history of breast cancer and young age at diagnosis of breast cancer increase risk of second primary malignancies in women: a population-based cohort study. Br J Cancer 95:1291-1295
45. Raymond JS, Hogue CJ (2006) Multiple primary tumours in women following breast cancer, 1973-2000. Br J Cancer 94:1745-1750
46. Yu GP, Schantz SP, Neugut AI, Zhang ZF (2006) Incidences and trends of second cancers in female breast cancer patients: a fixed inception cohort-based analysis (United States). Cancer Causes Control 17:411-420
47. Levi F, Te VC, Randimbison L, La Vecchia C (2003) Cancer risk in women with previous breast cancer. Ann Oncol 14:71-73
48. Evans HS, Lewis CM, Robinson D, Bell CM, Moller H, Hodgson SV (2001) Incidence of multiple primary cancers in a cohort of women diagnosed with breast cancer in southeast England. Br J Cancer 84:435-440
49. Volk N, Pompe-Kirn V (1997) Second primary cancers in breast cancer patients in Slovenia. Cancer Causes Control 8:764-770
50. Harvey EB, Brinton LA (1985) Second cancer following cancer of the breast in Connecticut, 1935-82. Natl Cancer Inst Monogr 68:99-112
51. Teppo L, Pukkala E, Saxen E (1985) Multiple cancer-an epidemiologic exercise in Finland. J Natl Cancer Inst 75:207-217
52. Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans E, Godwin J, Gray R, Hicks C, James S, MacKinnon E, McGale P, McHugh T, Peto R, Taylor C, Wang Y (2005) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366:2087-2106
53. Darby SC, McGale P, Taylor CW, Peto R (2005) Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol 6:557-565
54. Kirova YM, Vilcoq JR, Asselain B, Sastre-Garau X, Fourquet A (2005) Radiation-induced sarcomas after radiotherapy for breast carcinoma: a large-scale single-institution review. Cancer 104:856-863
55. Zablotska LB, Chak A, Das A, Neugut AI (2005) Increased risk of squamous cell esophageal cancer after adjuvant radiation therapy for primary breast cancer. Am J Epidemiol 161:330-337
56. Rubino C, de Vathaire F, Shamsaldin A, Labbe M, Le MG (2003) Radiation dose, chemotherapy, hormonal treatment and risk of second cancer after breast cancer treatment. Br J Cancer 89:840-846
57. Zablotska LB, Neugut AI (2003) Lung carcinoma after radiation therapy in women treated with lumpectomy or mastectomy for primary breast carcinoma. Cancer 97:1404-1411
58. Prochazka M, Granath F, Ekbom A, Shields PG, Hall P (2002) Lung cancer risks in women with previous breast cancer. Eur J Cancer 38:1520-1525
59. Yap J, Chuba PJ, Thomas R, Aref A, Lucas D, Severson RK, Hamre M (2002) Sarcoma as a second malignancy after treatment for breast cancer. Int J Radiat Oncol Biol Phys 52:1231-1237
60. Scholl B, Reis ED, Zouhair A, Chereshnev I, Givel JC, Gillet M (2001) Esophageal cancer as second primary tumor after breast cancer radiotherapy. Am J Surg 182:476-480
61. Sun EC, Curtis R, Melbye M, Goedert JJ (1999) Salivary gland cancer in the United States. Cancer Epidemiol Biomarkers Prev 8:1095-1100
62. Saku T, Hayashi Y, Takahara O, Matsuura H, Tokunaga M, Tokunaga M, Tokuoka S, Soda M, Mabuchi K, Land CE (1997) Salivary gland tumors among atomic bomb survivors, 1950-1987. Cancer 79:1465-1475
63. Travis LB, Curtis RE, Inskip PD, Hankey BF (1995) Re: Lung cancer risk and radiation dose among women treated for breast cancer. J Natl Cancer Inst 87:60-61
64. Taghian A, de Vathaire F, Terrier P, Le M, Auquier A, Mouriesse H, Grimaud E, Sarrazin D, Tubiana M (1991) Long-term risk of sarcoma following radiation treatment for breast cancer. Int J Radiat Oncol Biol Phys 21:361-367
65. Adami HO, Bergkvist L, Krusemo U, Persson I (1984) Breast-cancer as a risk factor for other primary malignant diseases-a nationwide cohort study. J Natl Cancer Inst 73:1049-1055
66. Eerola H, Pukkala E, Pyrhonen S, Blomqvist C, Sankila R, Nevanlinna H (2001) Risk of cancer in BRCA1 and BRCA2 mutation-positive and -negative breast cancer families (Finland). Cancer Causes Control 12:739-746
67. Schairer C, Mink PJ, Carroll L, Devesa SS (2004) Probabilities of death from breast cancer and other causes among female breast cancer patients. J Natl Cancer Inst 96:1311-1321
68. Chen Y, Thompson W, Semenciw R, Mao Y (1999) Epidemiology of contralateral breast cancer. Cancer Epidemiol Biomarkers Prev 8:855-861
69. Boice JD Jr., Harvey EB, Blettner M, Stovall M, Flannery JT (1992) Cancer in the contralateral breast after radiotherapy for breast cancer. N Engl J Med 326:781-785
70. Satagopan JM, Ben Porat L, Berwick M, Robson M, Kutler D, Auerbach AD (2004) A note on competing risks in survival data analysis. Br J Cancer 91:1229-1235
71. van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, Voskuil DW, Schreiber GJ, Peterse JL, Roberts C, Marton MJ, Parrish M, Atsma D, Witteveen A, Glas A, Delahaye L, van d V, Bartelink H, Rodenhuis S, Rutgers ET, Friend SH, Bernards R (2002) A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347:1999-2009
72. Buyse M, Loi S, van't Veer L, Viale G, Delorenzi M, Glas AM, d'Assignies MS, Bergh J, Lidereau R, Ellis P, Harris A, Bogaerts J, Therasse P, Floore A, Amakrane M, Piette F, Rutgers E, Sotiriou C, Cardoso F, Piccart MJ (2006) Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer. J Natl Cancer Inst 98:1183-1192
73. Sorlie T, Wang Y, Xiao C, Johnsen H, Naume B, Samaha RR, Borresen-Dale AL (2006) Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms. BMC Genomics 7:127
74. Stovall M, Smith SA, Rosenstein M (1989) Tissue doses from radiotherapy of cancer of the uterine cervix. Med Phys 16:726-733